Ben Caplin (UCL Centre for Nephrology) was featured in an Observer article accompanying a Wellcome Images Award winning photograph highlighting the kidney disease affecting the rural population of Nicaragua.
Over the past two decades, there has been a marked increase in deaths from kidney failure across Central America due to an unknown cause. This condition, termed Mesoamerican nephropathy, is reaching epidemic proportions. It is now the leading cause of death amongst working age men in Nicaragua and is devastating the rural communities in the region where treatments for kidney failure such as dialysis or transplantation are unavailable.
UCL researchers have been awarded a prestigious EU H2020 TEAMING grant, in collaboration with a consortium of Portuguese Universities led by Prof Rui Reis at the University of Minho. The UCL team is led by Prof Jonathan Knowles, UCL Eastman Dental Institute. The other UCL investigators include Richard Day (Division of Medicine), Ivan Wall (Department of Biochemical Engineering), Giampietro Schiavo (Institute of Neurology), Andreas Schätzlein (School of Pharmacy), Vivek Mudera (Division of Surgery), Tim McHugh (Division of Infection and Immunity), Jane Kinghorn (Translational Research Office). The total value of the EU H2020 grant is €15M, of which UCL have been awarded €5.1M as part of the scheme. Portuguese partners will leverage additional national funding to an impressive total of around €100M over the 7 years duration of the grant. A key overarching focus for the TEAMING award will be to capture and accelerate clinical, innovation and enterprise activities.
Professor Rachel Batterham has been awarded the prestigious Sir Jules Thorn Award for Biomedical Award (£1,423 625) for 2016. This award supports a 5-year programme of translational biomedical research and was awarded following a competition among applicants sponsored by leading UK medical schools and NHS organisations. Rachel’s programme of research entitled “Maximising the health benefits of bariatric surgery” will utilise a precision medicine based approach to managing people with obesity based on deep phenotyping coupled with ‘omics’. Given the associated surgical risks and the severely restricted access to surgery the UK (<1% of eligible patients), maximizing the health benefits obtained from bariatric surgery is a key area of unmet clinical need. Rachel’s work will address this by undertaking clinical studies to